Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 739

Similar articles for PubMed (Select 19261026)

1.

In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.

De Giorgi V, Salvini C, Chiarugi A, Paglierani M, Maio V, Nicoletti P, Santucci M, Carli P, Massi D.

Int J Dermatol. 2009 Mar;48(3):312-21. doi: 10.1111/j.1365-4632.2009.03916.x.

PMID:
19261026
2.

Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.

Vidal D, Matías-Guiu X, Alomar A.

Clin Exp Dermatol. 2004 Sep;29(5):518-25.

PMID:
15347339
3.
4.

Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo.

Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R.

Arch Dermatol. 2003 Oct;139(10):1325-32.

PMID:
14568837
5.

Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.

Vidal D, Matías-Guiu X, Alomar A.

Br J Dermatol. 2004 Sep;151(3):656-62.

PMID:
15377354
6.

Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.

Berman B, Sullivan T, De Araujo T, Nadji M.

Br J Dermatol. 2003 Nov;149 Suppl 66:59-61.

PMID:
14616354
7.
8.

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

Urosevic M, Dummer R, Conrad C, Beyeler M, Laine E, Burg G, Gilliet M.

J Natl Cancer Inst. 2005 Aug 3;97(15):1143-53.

9.

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.

Schön M, Bong AB, Drewniok C, Herz J, Geilen CC, Reifenberger J, Benninghoff B, Slade HB, Gollnick H, Schön MP.

J Natl Cancer Inst. 2003 Aug 6;95(15):1138-49.

10.

Imiquimod in basal cell carcinoma: how does it work?

Dummer R, Urosevic M, Kempf W, Hoek K, Hafner J, Burg G.

Br J Dermatol. 2003 Nov;149 Suppl 66:57-8.

PMID:
14616353
11.
12.

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.

Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, Andres K, Amies M, Owens M.

Arch Dermatol. 2002 Sep;138(9):1165-71.

PMID:
12224977
13.

Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.

Wolf IH, Kodama K, Cerroni L, Kerl H.

Am J Dermatopathol. 2007 Jun;29(3):237-41.

PMID:
17519620
14.

Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.

Michalopoulos P, Yawalkar N, Brönnimann M, Kappeler A, Braathen LR.

Br J Dermatol. 2004 Oct;151(4):903-6.

PMID:
15491436
15.

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.

Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, Owens ML; Australasian Multicentre Trial Group.

J Am Acad Dermatol. 2001 May;44(5):807-13.

PMID:
11312429
16.

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

Eigentler TK, Kamin A, Weide BM, Breuninger H, Caroli UM, Möhrle M, Radny P, Garbe C.

J Am Acad Dermatol. 2007 Oct;57(4):616-21. Epub 2007 Jul 3.

PMID:
17610993
17.

Has imiquimod 5% cream a role in the management of recurrent basal cell carcinoma?

RUIZ-VILLAVERDE R, SANCHEZ-CANO D, BURKHARDT-PEREZ P, SINTES RN.

Eur J Dermatol. 2009 Sep-Oct;19(5):481-3. doi: 10.1684/ejd.2009.0741. Epub 2009 Jun 15.

PMID:
19527989
18.
19.

Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.

Huber A, Huber JD, Skinner RB Jr, Kuwahara RT, Haque R, Amonette RA.

Dermatol Surg. 2004 Mar;30(3):429-30.

PMID:
15008876
20.

Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.

Schön MP, Wienrich BG, Drewniok C, Bong AB, Eberle J, Geilen CC, Gollnick H, Schön M.

J Invest Dermatol. 2004 May;122(5):1266-76.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk